(CIDRAP News) The Department of Health and Human Services (HHS) recently provided a shield against damage claims related to the use of the antiviral drugs oseltamivir (Tamiflu) and zanamivir (Relenza) in the current H1N1 influenza pandemic.
HHS Secretary Kathleen Sebelius signed a notice extending liability protection under the Public Readiness and Emergency Preparedness (PREP) Act. It was published in the Federal Register on Jun 19.
(CIDRAP News) The global novel H1N1 influenza situation is drawing closer to the status of a true pandemic but is not there yet, the World Health Organization's (WHO's) lead spokesman on the issue said today.
"Globally we believe we're in phase 5 but are getting closer to phase 6," said Dr. Keiji Fukuda, the WHO assistant director-general for health security and the environment, referring to the WHO's pandemic alert phases.